http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-101058558-B

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_fadeb6745a1e19dd87d58caf6aa101d5
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_a4b1eac93fa8426bfd541c9e14e11860
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D215-233
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D407-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4709
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P3-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-47
filingDate 2007-05-28-04:00^^<http://www.w3.org/2001/XMLSchema#date>
grantDate 2013-04-10-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_524cae1a1d7c9bb36f2c875932bc7e6f
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0b30093b22b709ce11941e08f6c112d2
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_81a0c561c31af3c926c33ac3447a6744
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b489a7bd7d6e33cd2d5507f0cbca5cee
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_9bc56cc6e0ceda0000d5708adaeab0cf
publicationDate 2013-04-10-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber CN-101058558-B
titleOfInvention 4-Oxy-1(4H)-quinoline carboxylic acids compound and composition with aldose reductase inhibition activity and preparation method thereof
abstract The invention discloses a 4-oxy-1 (4H)-quinoline carboxyl compound and derivant with structure as general formula I and II, which provides tautomeric body, medicinal salt, medicinal solvent and medicinal composition and preparing method. The invention can treat diabetic cardiovascular and cerebrovascular disease, diabetic nephrosis, diabetic nerve pathology and complication.
priorityDate 2007-05-28-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-9313099-A1
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID7000
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID65176309
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID465859997
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID164018782
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID23008901
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID465280524
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID8438
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID465585430
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419546507
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID425556471
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID163859207
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID467452148
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID465818715

Total number of triples: 34.